At meeting held on 15 December 2016
Claris Lifesciences announced that the Board of Directors of the Company at the meeting held on 15 December 2016 has approved the sale and transfer of the 'Injectable Business' of Claris Lifesciences ('CLL' or 'the Company') by way of sale of the following subsidiary companies:Claris Injectables , Claris Pharmaservices, Elda International DMCC, Claris Lifesciences Inc., Claris Lifesciences (UK), Claris Lifesciences (Aust), Claris Lifesciences Philippines, INC.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
